X-139582456-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PVS1_ModerateBP6_Very_StrongBS1BS2
The NM_001171878.2(MCF2):āc.2570C>Gā(p.Ser857*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00193 in 1,207,273 control chromosomes in the GnomAD database, including 37 homozygotes. There are 631 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.010 ( 19 hom., 323 hem., cov: 23)
Exomes š: 0.0011 ( 18 hom. 308 hem. )
Consequence
MCF2
NM_001171878.2 stop_gained
NM_001171878.2 stop_gained
Scores
1
4
Clinical Significance
Conservation
PhyloP100: 0.225
Genes affected
MCF2 (HGNC:6940): (MCF.2 cell line derived transforming sequence) The oncogenic protein encoded by this gene is a guanine nucleotide exchange factor (GEF) that exerts control over some members of the Rho family of small GTPases. Several transcript variants encoding different isoforms have been found for this gene. These isoforms exhibit different expression patterns and varying levels of GEF activity.[provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.00503 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
BP6
Variant X-139582456-G-C is Benign according to our data. Variant chrX-139582456-G-C is described in ClinVar as [Benign]. Clinvar id is 777844.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0102 (1147/111964) while in subpopulation AFR AF= 0.0345 (1065/30837). AF 95% confidence interval is 0.0328. There are 19 homozygotes in gnomad4. There are 323 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 19 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MCF2 | NM_001171876.2 | c.*15C>G | 3_prime_UTR_variant | 29/29 | ENST00000519895.6 | NP_001165347.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MCF2 | ENST00000519895.6 | c.*15C>G | 3_prime_UTR_variant | 29/29 | 2 | NM_001171876.2 | ENSP00000430276.1 |
Frequencies
GnomAD3 genomes AF: 0.0102 AC: 1146AN: 111910Hom.: 19 Cov.: 23 AF XY: 0.00948 AC XY: 323AN XY: 34086
GnomAD3 genomes
AF:
AC:
1146
AN:
111910
Hom.:
Cov.:
23
AF XY:
AC XY:
323
AN XY:
34086
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00312 AC: 567AN: 181747Hom.: 9 AF XY: 0.00207 AC XY: 138AN XY: 66695
GnomAD3 exomes
AF:
AC:
567
AN:
181747
Hom.:
AF XY:
AC XY:
138
AN XY:
66695
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00108 AC: 1180AN: 1095309Hom.: 18 Cov.: 28 AF XY: 0.000853 AC XY: 308AN XY: 360983
GnomAD4 exome
AF:
AC:
1180
AN:
1095309
Hom.:
Cov.:
28
AF XY:
AC XY:
308
AN XY:
360983
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0102 AC: 1147AN: 111964Hom.: 19 Cov.: 23 AF XY: 0.00946 AC XY: 323AN XY: 34150
GnomAD4 genome
AF:
AC:
1147
AN:
111964
Hom.:
Cov.:
23
AF XY:
AC XY:
323
AN XY:
34150
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
0
ESP6500AA
AF:
AC:
115
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
397
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
FATHMM_MKL
Benign
N
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at